Editorial comment: Radiogenomics of glioblastoma: shifting the focus from tumor cells to immune microenvironment.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 36305901.
- Also identified by DOI 10.1007/s00330-022-09195-3.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
• The ICI score derived from gene expression profile of immune cells infiltrating GBM correlates with overall survival and is an effective prognostic biomarker.• In this study, the authors developed a radiomics-based machine learning model able to identify gene expression profiles of GBM intratumoral stromal and immune cells and predict the ICI score on the preoperative MRI scans with high accuracy.• Radiogenomics could potentially be applied in primary brain tumors to noninvasively assess the specific tumor immune characteristics, predict patients' prognosis and identify those patients with higher probability to respond to immunotherapy.
Medical subject headings
- Glioblastoma
- Brain Neoplasms